Saturday, January 8, 2022

FDA grants IND clearance for REGENXBIO's gene therapy trial for Duchenne - Clinical Trials Arena

RGX-202 is a one-time gene therapy that leverages the NAV AAV8 vector of REGENXBIO. It will deliver a transgene for a new microdystrophin that ...
https://www.google.com/url?rct=j&sa=t&url=https://www.clinicaltrialsarena.com/news/fda-regenxbio-duchenne-trial/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFi4IWL1lSc7mrXoIL7-2ukREK5-w
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...